Fallopian Tube Cancer Clinical Trials

A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating GEN-1 for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Tucson Arizona

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Sutter West Bay
San Francisco California

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Irvine California 92618

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Long Beach California

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Los Angeles California 90095

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Monterey California 93940

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Francisco California 94115

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Colorado

Denver Colorado 80218

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Florida

SCRI Florida Cancer Specialists
West Palm Beach Florida

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

UPDATED

Miami Florida 33136

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Miami Florida 33136

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Orlando Florida 32804

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Peritoneal Carcinomatosis or Fallopian Tube Cancer

Orlando Florida 32804

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Sarasota Florida 34239

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Tampa Florida 33612

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

West Palm Beach Florida 33401

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Georgia

Northside Hospital
Atlanta Georgia

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Memorial University Medical Center
Savannah Georgia 31404

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Augusta Georgia 30912

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

UPDATED

Gainesville Georgia 30501

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

Illinois

University of Chicago
Chicago Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Northwestern University
Evanston Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Chicago Illinois

A clinical research study of COTI2

UPDATED

Hinsdale Illinois 60521

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Hinsdale Illinois 60521

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

Indiana

IU Melvine and Bren Cancer Center
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

St. Vincent Hospital
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Franciscan St. Francis Health
Indianapolis Indiana

A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Iowa

UPDATED

Des Moines Iowa 50309

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

Kentucky

Lexington Kentucky 40536

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

UPDATED

Louisville Kentucky 40241

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Louisiana

Women’s Cancer Center
Covington Louisiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Women's Cancer Care
Covington Louisiana

A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

UPDATED

New Orleans Louisiana 70121

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Maine

Scarborough Maine 04074

A clinical research study of Gemcitabine and pazopanib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Scarborough Maine 04074

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Maryland

Baltimore Maryland 21287

A clinical research study of Gemcitabine and pazopanib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Baltimore Maryland 21204

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

UPDATED

Frederick Maryland 21701

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

UPDATED

Silver Spring Maryland 20902

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Massachusetts

Lahey Clinic
Burlington Massachusetts

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Boston Massachusetts 02215

A clinical research study of IMGN853, Bevacizumab, Carboplatin and Doxorubicin for the treatment of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer or Endometrial Cancer

Boston Massachusetts 02114

A clinical research study of IMGN853, Bevacizumab, Carboplatin and Doxorubicin for the treatment of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer or Endometrial Cancer

Boston Massachusetts 02114

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

UPDATED

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer